Summary:
Meridien Research is looking for individuals between the ages of 50 and 90 who have Alzheimer’s Disease or are experiencing increasing memory or thinking issues for a study to see if an investigational medication can potentially slow the progression of Alzheimer’s disease.
All studies administered by a board certified physician.
Qualified Participants Must:
• Be between the ages of 50 and 90
•
Have Alzheimer's Disease
Qualified Participants May Receive:
Eligible participants will receive study-related care, monitoring and investigational medication or placebo. Compensation for time and travel may be available to patient and caregiver.